Hôpital Archet 2

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Childhood cancers2 trials
• Acute lymphoblastic leukaemia1 trial
• Obesity1 trial
• Ovarian cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials
• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Centre Hospitalier Universitaire de Nice1 trial
• Centre Oscar Lambret1 trial
• Hospices Civils de Lyon1 trial
• Pfizer1 trial
• UNICANCER1 trial

Running trials

• Recruiting

  A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

  NCT05748171· Phase 2· Pfizer· Source

• Active, not recruiting

  National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

  NCT02867033· Centre Oscar Lambret· Source

• Active, not recruiting

  Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment

  NCT01376752· Phase 3· UNICANCER· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Childhood cancers1 recruiting
• Ovarian cancer1 recruiting

Closed trials

• Completed

  Ex Vivo Transformation of White Adipose Tissue (WAT) Into Brown Adipose Tissue (BAT) in Morbidly Obese Patients Using the Ex Vivo Adipocyte Expansion (ExAdEx) Approach: Proof of Concept. From White to Brown Adipose Tissue

  NCT05843747· Centre Hospitalier Universitaire de Nice· Source

• Completed

  Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing

  NCT04308603· Hospices Civils de Lyon· Source